6,152 Shares in ICU Medical, Inc. $ICUI Bought by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. purchased a new stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) in the third quarter, according to its most recent disclosure with the SEC. The firm purchased 6,152 shares of the medical instruments supplier’s stock, valued at approximately $987,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in ICUI. Illinois Municipal Retirement Fund lifted its holdings in shares of ICU Medical by 9.2% in the third quarter. Illinois Municipal Retirement Fund now owns 13,788 shares of the medical instruments supplier’s stock valued at $2,213,000 after buying an additional 1,162 shares during the period. Lido Advisors LLC grew its holdings in ICU Medical by 15.4% during the third quarter. Lido Advisors LLC now owns 3,707 shares of the medical instruments supplier’s stock worth $595,000 after acquiring an additional 494 shares during the period. Keybank National Association OH acquired a new position in ICU Medical during the third quarter worth about $510,000. Vise Technologies Inc. acquired a new position in ICU Medical during the third quarter worth about $227,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al raised its position in ICU Medical by 9.6% in the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 6,833 shares of the medical instruments supplier’s stock worth $1,097,000 after acquiring an additional 600 shares in the last quarter. 96.10% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, Director Elisha Finney sold 1,700 shares of ICU Medical stock in a transaction dated Friday, November 13th. The stock was sold at an average price of $179.00, for a total value of $304,300.00. Following the transaction, the director owned 4,871 shares of the company’s stock, valued at approximately $871,909. This trade represents a 25.87% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Virginia Sanzone sold 4,856 shares of ICU Medical stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $168.69, for a total value of $819,158.64. Following the completion of the transaction, the vice president directly owned 14,604 shares in the company, valued at $2,463,548.76. This represents a 24.95% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 6,621 shares of company stock valued at $1,135,094 in the last quarter. 2.10% of the stock is currently owned by corporate insiders.

ICU Medical Price Performance

Shares of ICUI traded up $1.97 during trading hours on Friday, hitting $179.27. 195,454 shares of the company were exchanged, compared to its average volume of 278,884. The company has a debt-to-equity ratio of 0.52, a current ratio of 2.37 and a quick ratio of 1.19. The company has a market capitalization of $4.48 billion, a PE ratio of 75.01, a PEG ratio of 2.23 and a beta of 0.88. The firm has a fifty day simple moving average of $163.72 and a 200-day simple moving average of $149.91. ICU Medical, Inc. has a one year low of $113.37 and a one year high of $192.85.

ICU Medical (NASDAQ:ICUI) last announced its earnings results on Thursday, November 5th. The medical instruments supplier reported $2.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.30. ICU Medical had a return on equity of 8.40% and a net margin of 2.76%. The company had revenue of $556.22 million for the quarter, compared to analyst estimates of $552.03 million. During the same period in the previous year, the firm earned $2.03 earnings per share. ICU Medical’s revenue for the quarter was up 4.4% compared to the same quarter last year. As a group, sell-side analysts predict that ICU Medical, Inc. will post 7.22 earnings per share for the current year.

Analysts Set New Price Targets

ICUI has been the subject of a number of research analyst reports. Needham & Company LLC upped their price target on shares of ICU Medical from $165.00 to $187.00 and gave the company a “buy” rating in a report on Friday, August 7th. Zacks Research cut shares of ICU Medical from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 28th. Weiss Ratings upgraded shares of ICU Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, October 8th. BTIG Research boosted their target price on shares of ICU Medical from $170.00 to $200.00 and gave the stock a “buy” rating in a report on Friday, August 7th. Finally, Wall Street Zen raised shares of ICU Medical from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 8th. Two analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, ICU Medical currently has a consensus rating of “Moderate Buy” and an average price target of $195.20.

ICU Medical Profile

ICU Medical is a medical technology company that develops, manufactures and markets products used in infusion therapy, vascular access and critical care. Its offerings include infusion pumps and related sets and accessories, IV solutions, needlefree connectors, and products designed to help protect healthcare workers when handling hazardous drugs. Founded in 1984, the company expanded its product portfolio through acquisitions, including the infusion systems business of Hospira in 2017 and Smiths Medical in 2022.